| Literature DB >> 23437082 |
Ying Xu1, Qing-quan Luo, Ming-guo Zhou.
Abstract
Four streptomycin-resistant isolates of Xanthomonas oryzae pv. oryzae (YNA7-1, YNA10-2, YNA11-2, and YNA12-2) were examined via PCR amplification for the presence of class 1, class 2, and class 3 integrons and aadA1 and aadA2 genes, which confer resistance to streptomycin and spectinomycin. The class 1 integrase gene intI1 and the aminoglycoside adenylyltransferase gene aadA1 were identified in all four resistant isolates but not in 25 sensitive isolates. PCR amplifications showed that 7790-bp, 7162-bp, 7790-bp, and 7240-bp resistance integrons with transposition gene modules (tni module) in 3' conserved segments existed in YNA7-1, YNA10-2, YNA11-2, and YNA12-2, respectively. Subsequent analysis of sequences indicated that the integrons of YNA7-1 and YNA11-2 carried three gene cassettes in the order |aacA3|arr3|aadA1|. The integron of YNA10-2 carried only |arr3|aadA1| gene cassettes. The integron of YNA12-2 lacked a 550-bp sequence including part of intI1 but it still carried |aacA3|arr3|aadA1| gene cassettes. The analysis of inactive mutants and complementation tests confirmed that the aacA3 gene conferred resistance to tobramycin, kanamycin, gentamicin and netilmicin; the arr3 gene conferred resistance to rifampicin; and the aadA1 gene conferred resistance to streptomycin and spectinomycin. The resistance phenotypes of the four isolates corresponded with their resistance gene cassettes, except that YNA7-1 and YNA12-2 did not show rifampicin resistance. Sequence comparison revealed that no gene cassette array in GenBank was in the same order as in the integrons of the four resistant isolates in this study and the aadA1, which was identical in the four resistant isolates, showed 99% identity with aadA1 sequences in GenBank. The result of a stability test showed that the resistance phenotype, the aadA1 gene, and the intI1 gene were completely stable in YNA7-1 and YNA12-2 but unstable in YNA10-2 and YNA11-2. To our knowledge, this is the first report of resistance integron in a phytopathogenic bacteria.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23437082 PMCID: PMC3578876 DOI: 10.1371/journal.pone.0055962
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Bacterial strains and plasmids.
| Strain or plasmid | Relevant characteristics | Source or reference |
| Strain | ||
|
| ||
| YNA7-1 | Wild-type resistant isolate, containing resistance integron | Lab collection |
| YNA10-2 | Wild-type resistant isolate, containing resistance integron | Lab collection |
| YNA11-2 | Wild-type resistant isolate, containing resistance integron | Lab collection |
| YNA12-2 | Wild-type resistant isolate, containing resistance integron | Lab collection |
| YNA11-1 | Wild-type sensitive isolate | Lab collection |
| YNA22-2 | Wild-type sensitive isolate | Lab collection |
| ZJ173 | Wild-type sensitive isolate | Lab collection |
| PXO99 | Wild-type sensitive isolate | Lab collection |
| PXO1-1 | PXO99 with pUFRaacA3, Kmr, Gmr/Tobr/Ntlr | this study |
| PXO2-1 | PXO99 with pUFRarr3, Kmr, Rifr | this study |
| PXO3-1 | PXO99 with pUFRaadA1, Kmr, Smr/Spr | this study |
| PXO4-1 | PXO99 with pUFRintegron, Kmr, Gmr/Tobr/Ntlr, Rifr, Smr/Spr | this study |
| MaacA3 |
| this study |
| Marr3 |
| this study |
| MaadA1 |
| this study |
|
| ||
| DH5α | F−,φ80d | Takara |
| Plasmids | ||
| pMD18-T | Ampr, | Takara |
| pUFR034 | Kmr, |
|
| pUFRintegron | A fragment containing the ORF of | this study |
| pUFRaacA3 | an | this study |
| pUFRarr3 | an | this study |
| pUFRaadA1 | an | this study |
Sm, streptomycin; Km, kanamycin; Gm, gentamicin; Amp, ampicillin; Rif, rifampicin; Tob, tobramycin; Ntl, netilmicin; Sp, spectinomycin; r indicates resistance to the antibiotic; s indicates susceptibility to the antibiotic.
PCR amplification of integron-related genes from streptomycin-sensitive and -resistant isolates of X. oryzae pv. oryzae a.
| Isolate | Streptomycin susceptibility | Gene or primer pair | |||||||||||
|
|
|
|
|
| IRI andaadA1-R |
|
| intI-Rand IRT | IRI and TniR-a |
| |||
| YNA7-1 | R | + | − | − | + | − | + | − | − | − | + | + | |
| YNA10-2 | R | + | − | − | + | − | + | − | − | − | + | + | |
| YNA11-2 | R | + | − | − | + | − | + | − | − | − | + | + | |
| YNA12-2 | R | + | − | − | + | − | + | − | − | − | + | + | |
| ZJ173 | S | − | − | − | − | − | ND | ND | ND | ND | ND | + | |
| YNA11-1 | S | − | − | − | − | − | ND | ND | ND | ND | ND | + | |
| YNA22-2 | S | − | − | − | − | − | ND | ND | ND | ND | ND | + | |
+ and − indicate positive and negative PCR amplification; ND indicates not determined.
R indicates resistance to streptomycin and S indicates susceptibility to streptomycin.
Figure 1Structural organization of integrons in four resistant isolates of Xanthomonas oryzae pv. oryzae.
A. YNA7-1 and YNA11-2; B. YNA10-2; C. YNA12-2. The complete sequences of the resistance integrons in the four resistant isolates through PCR with primer pairs TniR-a and IRI, TniaR and TniA. The resistance integrons in YNA7-1, YNA10-2, YNA11-2, and YNA12-2 contained 7790, 7162, 7790, and 7240 bp, respectively. The sequence of tni module was long and not completely shown in this figure. The sequences of the resistance integrons of YNA7-1 and YNA11-2 were identical. Compared with YNA7-1 and YNA11-2, the sequence from position 1350 to 1977 was absent in the resistance integron of YNA10-2, and the sequence from 791 to 1340 was absent in the resistance integron of YNA12-2. Location of some primers used for PCR is shown in the figure. P1 and p2 are promoter areas of integrons.
Characteristics of resistance integrons in four resistant isolates of X. oryzae pv. oryzae.
| Isolate | Integron size (bp) | Array of gene cassettes | Antibiotic resistance phenotype |
| YNA7-1 | 7790 | | | Tob/Gm/Ntl/Km, Sm/Sp |
| YNA10-2 | 7162 | | | Rif, Sm/Sp |
| YNA11-2 | 7790 | | | Tob/Gm/Ntl/Km, Rif, Sm/Sp |
| YNA12-2 | 7240 | | | Tob/Gm/Ntl/Km, Sm/Sp |
Antibiotic resistance phenotype: Tob, tobramycin; Gm, gentamicin; Ntl, netilmicin; Km, kanamycin; Rif, rifampicin; Sm, streptomycin; Sp, spectinomycin.
Predicted genes in resistance integrons in four resistant isolates of X. oryzae pv. oryzae and the alignment of these genes relative to those in GenBank.
| Gene | Position | Length (bp) | YNA10-2 | YNA12-2 | Identity | Accession no. | Description of the identical gene |
| Incomplete IRi | 1–19 | 19 | Same | Same | 100% | AY033653.3 |
|
| Partial 5′CS | 20–196 | 177 | Same | Same | 100% | AY033653.3 |
|
|
| 197–1210 | 1014 | Same | Absent 791–1340 | 100% | GQ293501.1 |
|
| P1 promotor area | 1095–1123 | 29 | Same | Absent 791–1340 | 100% | GQ293501.1 |
|
| P2 promotor area | 1214–1239 | 26 | Same | Absent 791–1340 | 100% | GQ293501.1 |
|
|
| 1295–1352 | 58 | Absent 1350–1977 | Absent 791–1340 | 100% | DQ914960.2 |
|
|
| 1372–1926 | 555 | Absent 1350–1977 | Same | 100% | EF127959.1 |
|
|
| 1921–1980 | 60 | Absent 1350–1977 | Same | 100% | EF127959.1 |
|
|
| 2011–2463 | 453 | Same | Same | 100% | EU340416 |
|
|
| 2470–2583 | 114 | Same | Same | 100% | FM207631.1 |
|
|
| 2587–3378 | 792 | Same | Same | 99% | EF527229.1 |
|
|
| 3380–3439 | 60 | Same | Same | 100% | EF527229.1 |
|
|
| 3536–7790 | 4255 | Same | Same | 100% |
|
|
Positions were defined by the order of integron of YNA7-1 and YNA11-2.
Maximum identity at nucleotide acid level.
Accession no. of most similar gene in GenBank.
The MIC (minimum inhibitory concentration, µg/ml) of X. oryzae pv. oxyzae isolates to diverse antibiotics.
| Isolate | Antibiotic | ||||||
| Streptomycin | Spectinomycin | Tobramycin | Kanamycin | Netilmicin | Gentamicin | Rifampicin | |
| YNA7-1 | 300 | >500 | 10 | 100 | 100 | 100 | 0.1 |
| YNA10-2 | 300 | >500 | 1 | 1 | 1 | 1 | 10 |
| YNA11-2 | 300 | >500 | 10 | 100 | 100 | 100 | 10 |
| YNA12-2 | 300 | >500 | 10 | 100 | 100 | 50 | 0.1 |
| ZJ173 | 1 | 5 | 1 | 1 | 1 | 1 | 0.1 |
| YNA11-1 | 1 | 5 | 1 | 1 | 1 | 1 | 0.1 |
| YNA22-2 | 1 | 1 | 1 | 1 | 1 | 1 | 0.1 |
| PXO99 | 1 | 5 | 1 | 1 | 1 | 1 | 0.1 |
| YNA11-2* | 200 | >500 | 50 | 100 | 100 | 50 | 10 |
| PXO1-1 | ND | ND | 50 | >100 | 100 | 50 | ND |
| PXO2-1 | ND | ND | ND | >100 | ND | ND | 10 |
| PXO3-1 | 100 | >500 | ND | >100 | ND | ND | ND |
| PXO4-1 | 100 | >500 | 50 | >100 | 100 | 50 | 10 |
| MaacA3 | 100 | >500 | 1 | 1 | 1 | 1 | 5 |
| Marr3 | 50 | >500 | 50 | 50 | 100 | 50 | 0.5 |
| MaadA1 | 1 | 5 | 50 | 50 | 100 | 50 | 10 |
YNA11-2* was an isolate of YNA11-2 which has been preserved under low-temperature for three years.
Figure 2Construction and analysis of resistance gene mutants.
A. Schematic representation of homologous single recombination between a target resistance gene fragment cloned in pMD18-T and the target resistance gene in YNA11-2. Location of primers used for PCR is shown in the figure. The shaded box areas represent the target resistance gene while the lightly shaded area represents a cloned resistance gene fragment where homologous recombination occurred between pMD18-T and the genome of YNA11-2. When the mutant MaacA3 was analyzed, the primer accyan1-S, accyan1-A, accyan2-S and accyan2-A were used as the p1-S, p1-A, p2-S and p2-A, respectively. When the mutant Marr3 was analyzed, the primer arryan2-S, arryan2-A, arryan4-S and arryan4-A were used as the p1-S, p1-A, p2-S and p2-A, respectively. When the mutant MaadA1 was analyzed, the primer aadayan4-S, aadayan4-A, aadayan5-S and aadayan5-A were used as the p1-S, p1-A, p2-S and p2-A, respectively. B. Electrophoresis of three resistance genes fragments and PCR identification of three mutants. M1, DNA markers; Lane 1–3, PCR products of three resistance genes fragments FaacA3, Farr3 and FaadA1; Lane 4–9, PCR products of MaacA3 with primer pairs p1 and p2, PCR products of Marr3 with primer pairs p1 and p2, PCR products of MaadA1 with primer pairs p1 and p2; M2, DNA markers.